Browsing Tag
Clene Inc.
1 post
Is biomarker-driven approval the breakthrough ALS drug development has been waiting for?
Can neurofilament light fast-track ALS drug approvals? Explore how Clene Inc.’s FDA signal could reshape timelines, risk, and competition.